Sandi Peterson

Sandi Peterson was appointed as Chairman of Cynosure’s Board of Directors in December 2019 when global private equity firm, Clayton, Dubilier & Rice (CD&R) acquired Cynosure. She joined CD&R in 2019. Prior to CD&R, she was group worldwide chairman of Johnson & Johnson, where she led the consumer and medical devices businesses and was responsible for the corporation’s global supply chain, as well as its technology strategy and infrastructure. Previously, Ms. Peterson served as CEO of Bayer CropScience AG, CEO of Bayer Medical Care, and president of Bayer HealthCare AG’s Diabetes Care Division. She started her career at McKinsey and has held executive positions at Medco Health Solutions (formerly known as Merck-Medco), Nabisco, and Whirlpool.

Ms. Peterson is a member of the Microsoft Board of Directors and is on the board of trustees of the Institute for Advanced Study, the world-renowned center for science and humanities research in Princeton, NJ. She has appeared on Fortune magazine’s list of most powerful women numerous times and was featured on the magazine’s inaugural list of leaders changing healthcare.

Current CD&R Directorships: Cynosure (Chairman).

Education: Princeton University (MPA, Applied Economics), Cornell.